DESIGN OF THE SILENT CEREBRAL INFARCT TRANSFUSION (SIT) TRIAL

BACKGROUND: Silent cerebral infarct (SCI) is the most common cause of serious neurological disease in sickle cell anemia (SCA), affecting approximately 22% of children. The goal of this trial is to determine whether blood transfusion therapy will reduce further neurological morbidity in children wit...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Pediatr Hematol Oncol
Autors principals: Casella, James F., King, Allison A., Barton, Bruce, White, Desiree A., Noetzel, Michael J., Ichord, Rebecca N., Terrill, Cindy, Hirtz, Deborah, McKinstry, Robert C., Strouse, John J., Howard, Thomas H., Coates, Thomas D., Minniti, Caterina P, Campbell, Andrew D., Vendt, Bruce A., Lehmann, Harold, DeBaun, Michael R.
Format: Artigo
Idioma:Inglês
Publicat: 2010
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5572477/
https://ncbi.nlm.nih.gov/pubmed/20201689
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/08880010903360367
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars